tirzepatide and vyvanse Should I be concerned about increasing a patient's (lisdexamfetamine) dose from 30 mg to 40 mg? semaglutide and abilify What are

Compared to placebo (3.3%, 3.2 kg), patients lost a mean of 13.4% (13.5 kg) of body weight in the 10 mg group and 15.7% (15.6 kg) of body weight in the 15 mg group

I have been tracking my own body composition with DEXA scans since 2017

Snacking isn't required on GLP-1 medications, but strategic protein-rich snacks help you meet daily protein goals (100-120g) when main meals are smaller due to reduced appetite

In patients with type 2 DM, GLP-1R agonists have demonstrated a reduction in circumferential strain and improvement in markers of diastolic function, a key component of diabetic cardiomyopathy and the risk of developing heart failure